Thierry Boon

41.3k total citations · 13 hit papers
259 papers, 32.2k citations indexed

About

Thierry Boon is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Thierry Boon has authored 259 papers receiving a total of 32.2k indexed citations (citations by other indexed papers that have themselves been cited), including 215 papers in Immunology, 129 papers in Molecular Biology and 52 papers in Oncology. Recurrent topics in Thierry Boon's work include Immunotherapy and Immune Responses (204 papers), T-cell and B-cell Immunology (99 papers) and vaccines and immunoinformatics approaches (76 papers). Thierry Boon is often cited by papers focused on Immunotherapy and Immune Responses (204 papers), T-cell and B-cell Immunology (99 papers) and vaccines and immunoinformatics approaches (76 papers). Thierry Boon collaborates with scholars based in Belgium, France and United States. Thierry Boon's co-authors include Pierre van der Bruggen, Pierre G. Coulie, Etienne De Plaen, Aline Van Pel, Christophe Lurquin, Benoı̂t J. Van den Eynde, Bernard Lethé, Benoı̂t Van den Eynde, Catia Traversari and Patrick Chomez and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Thierry Boon

256 papers receiving 31.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1991 2.8k citations Pierre van der Bruggen, Patrick Chomez et al. Science profile →
Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase

2003 1.8k citations Catherine Uyttenhove, Ivan Théate et al. profile →
Tumor Antigens Recognized by T Lymphocytes

1994 1.0k citations Thierry Boon, Pierre van der Bruggen et al. profile →
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy

2014 845 citations Pierre G. Coulie, Benoı̂t J. Van den Eynde et al. profile →
The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

1993 785 citations Vincent Brichard, Aline Van Pel et al. The Journal of Experimental Medicine profile →
A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas.

1994 767 citations Pierre G. Coulie, Vincent Brichard et al. The Journal of Experimental Medicine profile →
Human tumor antigens recognized by T lymphocytes.

1996 685 citations Thierry Boon, Pierre van der Bruggen The Journal of Experimental Medicine profile →
Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes.

1994 645 citations Benoı̂t Van den Eynde, Pierre van der Bruggen et al. The Journal of Experimental Medicine profile →
Characterization of an Antigen That Is Recognized on a Melanoma Showing Partial HLA Loss by CTL Expressing an NK Inhibitory Receptor

1997 639 citations Bernard Lethé, Nicolas van Baren et al. profile →
A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.

1992 547 citations Pierre van der Bruggen, Christophe Lurquin et al. The Journal of Experimental Medicine profile →
Structure, chromosomal localization, and expression of 12 genes of the MAGE family

1994 513 citations Etienne De Plaen, Charles De Smet et al. Immunogenetics profile →
HUMAN T CELL RESPONSES AGAINST MELANOMA

2005 504 citations Thierry Boon, Pierre G. Coulie et al. profile →
A limiting dilution assay for quantifying Leishmania major in tissues of infected mice

1985 462 citations Thierry Boon et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thierry Boon Belgium	92	25.4k	15.0k	11.4k	2.8k	2.7k	259	32.2k
Pedro Romero Switzerland	85	19.9k 0.8×	8.6k 0.6×	9.8k 0.9×	1.4k 0.5×	1.5k 0.6×	343	26.7k
Harald von Boehmer United States	99	25.8k 1.0×	7.2k 0.5×	6.7k 0.6×	2.6k 0.9×	3.4k 1.3×	306	32.7k
Rolf Kiessling Sweden	81	16.8k 0.7×	5.5k 0.4×	7.3k 0.6×	1.5k 0.5×	1.1k 0.4×	313	22.9k
Günter J. Hämmerling Germany	79	12.8k 0.5×	5.7k 0.4×	4.3k 0.4×	1.9k 0.7×	1.5k 0.5×	232	19.7k
Kai W. Wucherpfennig United States	81	14.5k 0.6×	6.4k 0.4×	7.0k 0.6×	2.2k 0.8×	1.8k 0.7×	203	23.9k
Alessandro Moretta Italy	116	39.3k 1.5×	3.9k 0.3×	11.3k 1.0×	1.6k 0.6×	1.0k 0.4×	376	43.6k
Herbert C. Morse United States	81	12.1k 0.5×	8.0k 0.5×	3.6k 0.3×	1.6k 0.6×	2.5k 1.0×	437	22.8k
David H. Raulet United States	93	27.3k 1.1×	4.8k 0.3×	8.8k 0.8×	1.5k 0.5×	1.5k 0.6×	220	32.3k
Jason G. Cyster United States	91	23.3k 0.9×	9.3k 0.6×	6.3k 0.6×	1.6k 0.6×	1.1k 0.4×	171	32.2k
Paul M. Sondel United States	60	6.7k 0.3×	3.5k 0.2×	4.7k 0.4×	1.3k 0.5×	1.1k 0.4×	334	12.2k

Countries citing papers authored by Thierry Boon

Since Specialization

Citations

This map shows the geographic impact of Thierry Boon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thierry Boon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thierry Boon more than expected).

Fields of papers citing papers by Thierry Boon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thierry Boon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thierry Boon. The network helps show where Thierry Boon may publish in the future.

Co-authorship network of co-authors of Thierry Boon

This figure shows the co-authorship network connecting the top 25 collaborators of Thierry Boon. A scholar is included among the top collaborators of Thierry Boon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thierry Boon. Thierry Boon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cipponi, Arcadi, Marjorie Mercier, Teofila Seremet, et al.. (2012). Neogenesis of Lymphoid Structures and Antibody Responses Occur in Human Melanoma Metastases. Cancer Research. 72(16). 3997–4007. 204 indexed citations

Corbière, Véronique, Jacques Chapiro, Vincent Stroobant, et al.. (2011). Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases. Cancer Research. 71(4). 1253–1262. 142 indexed citations

François, Violaine, Nicolina Renkvist, Julie Stockis, et al.. (2009). The CD4+ T-Cell Response of Melanoma Patients to a MAGE-A3 Peptide Vaccine Involves Potential Regulatory T Cells. Cancer Research. 69(10). 4335–4345. 77 indexed citations

Chapiro, Jacques, Stéphane Claverol, Fanny Piette, et al.. (2006). Destructive Cleavage of Antigenic Peptides Either by the Immunoproteasome or by the Standard Proteasome Results in Differential Antigen Presentation. The Journal of Immunology. 176(2). 1053–1061. 125 indexed citations

Zhang, Yi, Zhaojun Sun, Hugues J. M. Nicolay, et al.. (2005). Monitoring of Anti-Vaccine CD4 T Cell Frequencies in Melanoma Patients Vaccinated with a MAGE-3 Protein. The Journal of Immunology. 174(4). 2404–2411. 26 indexed citations

Vigneron, Nathalie, Vincent Stroobant, Jacques Chapiro, et al.. (2004). An Antigenic Peptide Produced by Peptide Splicing in the Proteasome. Science. 304(5670). 587–590. 262 indexed citations

Karanikas, Vaios, Christophe Lurquin, Didier Colau, et al.. (2003). Monoclonal Anti-MAGE-3 CTL Responses in Melanoma Patients Displaying Tumor Regression after Vaccination with a Recombinant Canarypox Virus. The Journal of Immunology. 171(9). 4898–4904. 88 indexed citations

Zhang, Yi, Pascal Chaux, Vincent Stroobant, et al.. (2003). A MAGE-3 Peptide Presented by HLA-DR1 to CD4+ T Cells That Were Isolated from a Melanoma Patient Vaccinated with a MAGE-3 Protein. The Journal of Immunology. 171(1). 219–225. 35 indexed citations

Godelaine, Danièle, Javier Carrasco, Sophie Lucas, et al.. (2003). Polyclonal CTL Responses Observed in Melanoma Patients Vaccinated with Dendritic Cells Pulsed with a MAGE-3.A1 Peptide. The Journal of Immunology. 171(9). 4893–4897. 79 indexed citations

10.

Bilsborough, Janine, Catherine Uyttenhove, Didier Colau, et al.. (2002). TNF-Mediated Toxicity After Massive Induction of Specific CD8+ T Cells Following Immunization of Mice with a Tumor-Specific Peptide. The Journal of Immunology. 169(6). 3053–3060. 17 indexed citations

11.

Baurain, Jean‐François, Didier Colau, Nicolas van Baren, et al.. (2000). High Frequency of Autologous Anti-Melanoma CTL Directed Against an Antigen Generated by a Point Mutation in a New Helicase Gene. The Journal of Immunology. 164(11). 6057–6066. 83 indexed citations

12.

Brasseur, Francis, et al.. (2000). Cytolytic T Lymphocytes Raised Against a Human Bladder Carcinoma Recognize an Antigen Encoded by Gene MAGE-A12. The Journal of Immunology. 164(11). 6041–6045. 38 indexed citations

13.

Weynants, P., Joëlle Thonnard, Marie Marchand, et al.. (1999). Derivation of Tumor-specific Cytolytic T-Cell Clones from Two Lung Cancer Patients with Long Survival. American Journal of Respiratory and Critical Care Medicine. 159(1). 55–62. 32 indexed citations

14.

Smet, Charles De, et al.. (1999). DNA Methylation Is the Primary Silencing Mechanism for a Set of Germ Line- and Tumor-Specific Genes with a CpG-Rich Promoter. Molecular and Cellular Biology. 19(11). 7327–7335. 499 indexed citations

15.

Boon, Thierry. (1998). Tumor antigens recognized by cytolytic T cells. Digital Access to Libraries. 46(2). 124–124. 6 indexed citations

16.

Warnier, Guy, Catherine Uyttenhove, Thomas F. Gajewski, et al.. (1996). Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A. International Journal of Cancer. 67(2). 303–310. 47 indexed citations

17.

Skipper, Jonathan, Ronald C. Hendrickson, Pamela H. Gulden, et al.. (1996). An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins.. The Journal of Experimental Medicine. 183(2). 527–534. 346 indexed citations

18.

Bruggen, Pierre van der, Benoı̂t Van den Eynde, Pierre G. Coulie, et al.. (1995). Genes encoding human tumor-antigens recognized by cytolytic T-lymphocytes. Journal of Cellular Biochemistry. 6–6. 2 indexed citations

19.

Chomez, Patrick, et al.. (1995). The SMAGE gene family is expressed in post-meiotic spermatids during mouse germ cell differentiation. Immunogenetics. 43(1-2). 97–100. 31 indexed citations

20.

Hainaut, Philippe, P. Weynants, Pierre G. Coulie, & Thierry Boon. (1990). Antitumor Lymphocyte-t Responses. Immunology and Allergy Clinics of North America. 10(4). 639–662. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact